The DOI matches its Crossref record; 219 of the 220 references it cites were found in a registry or an index.
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Open accessAbstract
Cancer represents a group of heterogeneous diseases characterized by uncontrolled growth and spread of abnormal cells, ultimately leading to death. Nanomedicine plays a significant role in the development of nanodrugs, nanodevices, drug delivery systems and nanocarriers. Some of the major issues in the treatment of cancer are multidrug resistance (MDR), narrow therapeutic window and undesired side effects of available anticancer drugs and the limitations of anticancer drugs. Several nanosystems being utilized for detection, diagnosis and treatment such as theranostic carriers, liposomes, carbon nanotubes, quantum dots, polymeric micelles, dendrimers and metallic nanoparticles. However, nonbiodegradable nanoparticles causes high tissue accumulation and leads to toxicity. MDR is considered a major impediment to cancer treatment due to metastatic tumors that develop resistance to chemotherapy. MDR contributes to the failure of chemotherapies in various cancers, including breast, ovarian, lung, gastrointestinal and hematological malignancies. Moreover, the therapeutic efficiency of anticancer drugs or nanoparticles (NPs) used alone is less than that of the combination of NPs and anticancer drugs. Combination therapy has long been adopted as the standard first-line treatment of several malignancies to improve the clinical outcome. Combination therapy with anticancer drugs has been shown to generally induce synergistic drug actions and deter the onset of drug resistance. Therefore, this review is designed to report and analyze the recent progress made to address combination therapy using NPs and anticancer drugs. We first provide a comprehensive overview of the angiogenesis and of the different types of NPs currently used in treatments of cancer; those emphasized in this review are liposomes, polymeric NPs, polymeric micelles (PMs), dendrimers, carbon NPs, nanodiamond (ND), fullerenes, carbon nanotubes (CNTs), graphene oxide (GO), GO nanocomposites and metallic NPs used for combination therapy with various anticancer agents. Nanotechnology has provided the convenient tools for combination therapy. However, for clinical translation, we need continued improvements in the field of nanotechnology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Historically, drug combinations have been utilized efficiently to treat various bacterial and viral infections and to fight cancer [18–21].”
From Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yuan, Y., Peng, Q., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s136142 · Cited by 52
Self-citationRetractedJemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S. M., Négrier, S., Szczylik, C. A., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,752
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2016) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,392
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B. J., Eisen, T. G., Stadler, W. M., Szczylik, C. A., Oudard, S. M., Siebels, M., Négrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,854
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati‐Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,648
Zhang, X., Liu, Z.-G., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091534 · Cited by 3,379
Self-citationThe properties and applications of nanodiamonds
Mochalin, V. N., Shenderova, O. A., Ho, D., & Gogotsi, Y. G. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.209 · Cited by 2,762
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J. N., Gole, A. M., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,299
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,834
Bean, C. P., & Livingston, J. D. (1959) · Journal of Applied Physics · doi:10.1063/1.2185850 · Cited by 1,790
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,774
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,731
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Graphene and graphene oxide as new nanocarriers for drug delivery applications
Liu, J., Cui, L., & Lošić, D. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.016 · Cited by 1,353
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati‐Koshki, K., & Pashaei‐Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,283
Organic Functionalization of Carbon Nanotubes
Georgakilas, V. I., Kordatos, K., Prato, M., Guldi, D. M., Holzinger, M., & Hirsch, A. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016954m · Cited by 1,193
Dendrimer biocompatibility and toxicity
Duncan, R., & Izzo, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,153
Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146
Introduction to metallic nanoparticles
Mody, V. V., Siwale, R. C., Singh, A. V., & Mody, H. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72127 · Cited by 1,082
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,073
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 992
Discovery of dendrimers and dendritic polymers: A brief historical perspective*
Tomalia, D. A., & Fréchet, J. M. J. (2002) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.10301 · Cited by 932
Gurunathan, S., Han, J. W., Dayem, A. A., Eppakayala, V., & Kim, J. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37397 · Cited by 930
Self-citationChitosan‐Functionalized Graphene Oxide as a Nanocarrier for Drug and Gene Delivery
Bao, H., Pan, Y., Yuan, P., Sahoo, N. G., Wu, T., Li, L., Li, J., & Gan, L. H. (2011) · Small · doi:10.1002/smll.201100191 · Cited by 901
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F. (2009) · ACS Nano · doi:10.1021/nn800551s · Cited by 852
Cellular abnormalities of blood vessels as targets in cancer
Bałuk, P., Hashizume, H., & McDonald, D. M. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 782
Narayanan, R., & El‐Sayed, M. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja035044x · Cited by 780
Polymeric micelles as new drug carriers
Kwon, G. S., & Okano, T. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00401-2 · Cited by 725
Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.11.067 · Cited by 719
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Cancer nanomedicine: from targeted delivery to combination therapy
Xu, X., Ho, W., Zhang, X., Bertrand, N., & Farokhzad, O. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.001 · Cited by 693
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 663
[60]Fullerene is a Powerful Antioxidant in Vivo with No Acute or Subacute Toxicity
Gharbi, N., Pressac, M., Hadchouel, M., Szwarc, H., Wilson, S. R., & Moussa, F. (2005) · Nano Letters · doi:10.1021/nl051866b · Cited by 657
Particle Size Dependence of Coercivity and Remanence of Single-Domain Particles
Kneller, E., & Luborsky, F. E. (1963) · Journal of Applied Physics · doi:10.1063/1.1729324 · Cited by 657
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer‐Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 622
Zhang, L., Lu, Z., Zhao, Q., Huang, J., Shen, H., & Zhang, Z. (2011) · Small · doi:10.1002/smll.201001522 · Cited by 596
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Chow, E. K., Zhang, X., Chen, M., Lam, R. T.-T., Robinson, E. M., Huang, H., Schaffer, D. J., O̅sawa, E., Goga, A., & Ho, D. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001713 · Cited by 561
Zhang, X., Meng, L., Lu, Q., Fei, Z., & Dyson, P. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.025 · Cited by 540
Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X.-L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.001 · Cited by 529
Lee, C. K., Brown, C. S. B., Gralla, R. J., Hirsh, V., Thongprasert, S., Tsai, C., Tan, E. H., Ho, J., Chu, D., Zaatar, A., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt072 · Cited by 511
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 481
Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · Drug Target Insights · doi:10.1177/117739280700200002 · Cited by 462
Platinum nanoparticles: a promising material for future cancer therapy?
Porcel, E., Liehn, S., Remita, H., Usami, N., Kobayashi, K., Furusawa, Y., Sech, C. L., & Lacombe, S. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/8/085103 · Cited by 423
Carbon Nanohorns as Anticancer Drug Carriers
Ajima, K., Yudasaka, M., Murakami, T., Maignè, A., Shiba, K., & Iijima, S. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500566 · Cited by 413
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
Watermann, A., & Brieger, J. (2017) · Nanomaterials · doi:10.3390/nano7070189 · Cited by 404
Gupta, A. K., & Curtis, A. S. G. (2004) · Journal of Materials Science Materials in Medicine · doi:10.1023/b:jmsm.0000021126.32934.20 · Cited by 402
Judson, I. R., Radford, J. A., Harris, M., Blay, J., van Hoesel, Q., Cesne, A. L., van Oosterom, A. T., Clemons, M. J., Kamby, C., Hermans, C., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00050-8 · Cited by 392
Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Rini, B. I., Tamaskar, I., Shaheen, P., Salas, R. N., Garcia, J., Wood, L. S., Reddy, S. S. K., Dreicer, R., & Bukowski, R. M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk008 · Cited by 378
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Ma, J., & Waxman, D. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0715 · Cited by 376
Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics
Ali‐Boucetta, H., Al‐Jamal, K. T., McCarthy, D., Prato, M., Bianco, A., & Kostarelos, K. (2008) · Chemical Communications · doi:10.1039/b712350g · Cited by 372
Risk of prostate carcinoma death in patients with lymph node metastasis
Liang Cheng, C., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B. G., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1 · Cited by 359
β-catenin mutation and overexpression in hepatocellular carcinoma
Wong, C., Fan, S. T., & Ng, I. O. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1 · Cited by 353
Sahoo, N. G., Bao, H., Pan, Y., Pal, M., Kakran, M., Cheng, H. K. F., Li, L., & Tan, L. P. (2011) · Chemical Communications · doi:10.1039/c1cc00075f · Cited by 341
Patil, Y. B., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 319
Nanodiamond-Mediated Delivery of Water-Insoluble Therapeutics
Chen, M., Pierstorff, E. D., Lam, R. T.-T., Li, S.-Y., Huang, H., O̅sawa, E., & Ho, D. (2009) · ACS Nano · doi:10.1021/nn900480m · Cited by 318
Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model
Zhang, X., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101603 · Cited by 316
Self-citationCost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer
Nguyen, P. L., Gu, X., Lipsitz, S. R., Choueiri, T. K., Choi, W. W., Lei, Y., Hoffman, K. E., & Hu, J. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1217 · Cited by 308
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · PubMed · Cited by 302
Yang, Z., Li, J., Wang, Z.-Z., Dong, D., & Qi, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.017 · Cited by 268
Anticancer strategies involving the vasculature
Heath, V. L., & Bicknell, R. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.52 · Cited by 254
Zhang, X., Lam, R. T.-T., Xu, X., Chow, E. K., Kim, H., & Ho, D. (2011) · Advanced Materials · doi:10.1002/adma.201102263 · Cited by 251
Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs
Shin, H.-C., Alani, A. W. G., Rao, D. A., Rockich, N. C., & Kwon, G. S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.024 · Cited by 243
Lai, P., Lou, P., Peng, C., Pai, C., Yen, W.-N., Huang, M., Young, T., & Shieh, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.012 · Cited by 240
Lammers, T., Šubr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Nanodiamond as a Vector for siRNA Delivery to Ewing Sarcoma Cells
Alhaddad, A., Adam, M., Botsoa, J., Dantelle, G., Perruchas, S., Gacoin, T., Mansuy, C., Lavielle, S., Malvy, C., Treussart, F., et al. (2011) · Small · doi:10.1002/smll.201101193 · Cited by 239
Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy
Qin, X., Guo, Z., Liu, Z. M., Zhang, W., Wan, M., & Yang, B. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.12.005 · Cited by 235
Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods
Huang, Y., Sefah, K., Bamrungsap, S., Chang, H., & Tan, W. (2008) · Langmuir · doi:10.1021/la801969c · Cited by 234
Pastorino, F., Brignole, C., Paolo, D. D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 233
Current State of Circulating MicroRNAs as Cancer Biomarkers
He, Y., Lin, J., Kong, D., Huang, M., Xu, C., Kim, T., Etheridge, A., Luo, Y., Ding, Y., & Wang, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241190 · Cited by 231
Liu, X., Guan, Y., Ma, Z., & Liu, H. (2004) · Langmuir · doi:10.1021/la0491908 · Cited by 230
Nanodiamonds as intracellular transporters of chemotherapeutic drug
Li, J., Zhu, Y. J., Li, W., Zhang, X., Peng, Y., & Huang, Q. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.058 · Cited by 225
Bisht, S., Mizuma, M., Feldmann, G., Ottenhof, N. A., Hong, S., Pramanik, D., Chenna, V., Karikari, C. A., Sharma, R. B., Goggins, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0172 · Cited by 216
Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy
Liu, K., Zheng, W., Wang, C., Chiu, Y.-C., Cheng, C., Lo, Y.-S., Chen, C., & Chao, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/31/315106 · Cited by 213
Wang, J., Liu, C., Shuai, Y., Cui, X., & Ling, N. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.09.009 · Cited by 210
Fang, W., Tang, S., Liu, P., Fang, X., Gong, J., & Zheng, N. (2012) · Small · doi:10.1002/smll.201200962 · Cited by 208
Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy
Bai, J., Liu, Y., & Jiang, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.008 · Cited by 207
Zheng, C., Zheng, M., Gong, P., Deng, J., Yi, H., Zhang, P., Zhang, Y., Liu, P., Ma, Y., & Cai, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.053 · Cited by 204
Implications of silver nanoparticle induced cell apoptosis forin vitrogene therapy
Gopinath, P., Gogoi, S. K., Chattopadhyay, A., & Ghosh, S. S. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/7/075104 · Cited by 202
Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.049 · Cited by 200
Gurunathan, S., Han, J. W., Kim, E., Park, J. H., & Kim, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79879 · Cited by 193
Self-citationKoukourakis, M. I., Koukouraki, S. I., Giatromanolaki, A. N., Archimandritis, S. C., Skarlatos, J., Beroukas, K., Bizakis, J. G., Retalis, G., Karkavitsas, N., & Helidonis, E. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3512 · Cited by 191
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
Sund, M., Hamano, Y., Sugimoto, H., Sudhakar, A., Soubasakos, M. A., Yerramalla, U. L., Benjamin, L. E., Lawler, J., Kieran, M. W., Shah, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500180102 · Cited by 182
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
Sun, T., Wang, Y., Wang, F., Du, J., Mao, C., Sun, C., Tang, R.-Z., Liu, Y., Zhu, J., Zhu, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.011 · Cited by 176
Zhang, X., Dong, Y., Zeng, X., Liang, X., Li, X., Wei, T., Chen, H., Jiang, Y., Mei, L., & Feng, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.034 · Cited by 175
Bae, Y., Diezi, T. A., Zhao, A., & Kwon, G. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.038 · Cited by 174
Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?
Cui, L., Her, S., Borst, G. R., Bristow, R. G., Jaffray, D. A., & Allen, C. J. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.007 · Cited by 169
Lee, S. J., Park, K., Oh, Y., Kwon, S., Her, S., Kim, I.-S., Choi, K., Lee, S. J., Kim, H., Lee, S. G., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.058 · Cited by 168
Pan, H., Liu, L., & Cai, L. (2022) · Biomaterial engineering · doi:10.1007/978-981-16-5419-0_18 · Cited by 165
Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route
Maity, D., Choo, S.-G., Yi, J., Ding, J., & Xue, J. M. (2008) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2008.11.013 · Cited by 160
Jia, N., Lian, Q., Shen, H., Wang, C., Li, X., & Yang, Z. (2007) · Nano Letters · doi:10.1021/nl071114c · Cited by 156
Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment
Katiyar, S. S., Muntimadugu, E., Rafeeqi, T. A., Domb, A. J., & Khan, W. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1039667 · Cited by 153
Designing of ‘intelligent’ liposomes for efficient delivery of drugs
Voinea, M., & Simionescu, M. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00450.x · Cited by 152
Jiang, J., Yang, S.-J., Wang, J., Yang, L., Xu, Z.-Z., Yang, T., Liu, X.-Y., & Zhang, Q. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.011 · Cited by 149
Yuan, Y., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125281 · Cited by 146
Self-citationMignani, S. M., Bryszewska, M. J., Klajnert‐Maculewicz, B., Zabłocka, M., & Majoral, J. (2014) · Biomacromolecules · doi:10.1021/bm501285t · Cited by 143
Poon, C. J., He, C., Liu, D., Lu, K., & Lin, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.026 · Cited by 136
Biodegradable amphiphilic polymer–drug conjugate micelles
Hu, X., & Jing, X. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903158917 · Cited by 135
Liposome and Their Applications in Cancer Therapy
Pandey, H., Rani, R., & Agarwal, V. K. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150477 · Cited by 132
Taratula, O. R., Schumann, C., Duong, T., Taylor, K. L., & Taratula, O. (2014) · Nanoscale · doi:10.1039/c4nr06050d · Cited by 129
Pan, Q., Lv, Y., Williams, G. R., Tao, L., Yang, H., Li, H., & Zhu, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.06.024 · Cited by 129
A systems approach to cancer therapy
Teicher, B. A. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437479 · Cited by 125
Li, J., Lyv, Z., Li, Y., Liu, H., Wang, J., Zhan, W., Chen, H., Chen, H., & Li, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.074 · Cited by 123
Khan, M. A., Zafaryab, M., Mehdi, S. H., Ahmad, I., & Rizvi, M. M. A. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.08.050 · Cited by 123
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
Clementi, C., Miller, K., Mero, A., Satchi‐Fainaro, R., & Pasut, G. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001445 · Cited by 121
Diamond‐Lipid Hybrids Enhance Chemotherapeutic Tolerance and Mediate Tumor Regression
Moore, L. K., Chow, E. K., O̅sawa, E., Bishop, J. M., & Ho, D. (2013) · Advanced Materials · doi:10.1002/adma.201300343 · Cited by 120
Na, K., Lee, K. H., Lee, D. H., & Bae, Y. H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.012 · Cited by 114
Jaeckle, K. A., Batchelor, T. T., O'Day, S. J., Phuphanich, S., New, P., Lesser, G. J., Cohn, A. L., Gilbert, M. R., Aiken, R. D., Heros, D. O., et al. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015752331041 · Cited by 113
Surfactant−Polymer Nanoparticles Enhance the Effectiveness of Anticancer Photodynamic Therapy
Khdair, A. A., Gérard, B., Handa, H., Mao, G., Shekhar, M. P. V., & Panyam, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800026t · Cited by 113
Iyer, A. K., Greish, K. F., Seki, T., Okazaki, S., Fang, J. Q., Takeshita, K., & Maeda, H. (2007) · Journal of drug targeting · doi:10.1080/10611860701498252 · Cited by 113
Blau, H. M., & Banfi, A. (2001) · Nature Medicine · doi:10.1038/87850 · Cited by 108
Sun, J., Wang, D.-A., Jain, R. K., Carie, A., Paquette, S., Ennis, E., Blaskovich, M. A., Baldini, L., Coppola, D., Hamilton, A. D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208391 · Cited by 108
Cao, X., Tao, L., Wen, S., Hou, W., & Shi, X. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.06.030 · Cited by 108
The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer
Campos, S. M., Penson, R. T., Mays, A. R., Berkowitz, R. S., Fuller, A. F., Goodman, A., Matulonis, U. A., Muzikansky, A., & Seiden, M. V. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.5980 · Cited by 107
Forssen, E. A., Malé-Brune, R., Adler‐Moore, J., Lee, M. J., Schmidt, P. G., Krasieva, T. B., Shimizu, S., & Tromberg, B. J. (1996) · PubMed · Cited by 103
Tomuleasa, C., Şoriţău, O., Orza, A. I., Dudea, M., Petrushev, B., Moșteanu, O., Șușman, S., Florea, A., Páll, E., Aldea, M. D., et al. (2012) · PubMed · Cited by 102
Yang, Y., Yang, Y., Xie, X., Wang, Z., Gong, W., Zhang, H., Li, Y., Yu, F., Li, Z., & Mei, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.030 · Cited by 101
Nanodiamond as the pH‐Responsive Vehicle for an Anticancer Drug
Guan, B., Zou, F., & Zhi, J. (2010) · Small · doi:10.1002/smll.200902305 · Cited by 101
Kumar, D. S., Hasumura, T., Nagaoka, Y., Yoshida, Maekawa, T., & Jeymohan, P. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s46054 · Cited by 100
Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene
Harhaji-Trajkovic, L. M., Isaković, A., Zogovic, N. S., Marković, Z. M., Marković, B. M. T., Nikolić, N., Vranješ‐Đurić, S., Marković, I., & Trajković, V. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.041 · Cited by 99
Buckysomes: Fullerene-Based Nanocarriers for Hydrophobic Molecule Delivery
Partha, R., Mitchell, L. R., Lyon, J. L. L., Joshi, P. P., & Conyers, J. L. (2008) · ACS Nano · doi:10.1021/nn800422k · Cited by 98
Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy
Dorniani, D., Saifullah, B., Barahuie, F., Arulselvan, P., Hussein, M. Z., Fakurazi, S., & Twyman, L. J. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1712-2 · Cited by 98
Xiong, H., Zhou, D., Qi, Y., Zhang, Z., Xie, Z., Chen, X., Jing, X., Meng, F., & Huang, Y. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01311 · Cited by 97
Atyabi, F., Sobhani, N., Adeli, M., Dinarvand, R., & Ghahremani (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17336 · Cited by 96
de Menezes, D. E. L., Hudon, N. J., McIntosh, N. L., & Mayer, L. D. (2000) · PubMed · Cited by 93
Shen, A., Li, D., Cai, X., Dong, C., Dong, H., Wen, H., Dai, G., Wang, P., & Li, Y. (2012) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34148 · Cited by 93
Salzano, G., Navarro, G., Trivedi, M. S., Rosa, G. D., & Torchilin, V. P. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0556 · Cited by 92
Xu, Q., Leong, J., Chua, Q. Y., Chi, Y. T., Chow, P. K. H., Pack, D. W., & Wang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.044 · Cited by 89
Hubert, A., Lyass, O., Pode, D., & Gabizón, A. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200002000-00009 · Cited by 87
Roby, A., Erdoğan, S., & Torchilin, V. P. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.010 · Cited by 87
Hu, J. X., Wang, J., Wang, G., Yao, Z., & Dang, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2458 · Cited by 87
Sasikala, A. R. K., Thomas, R. G., Unnithan, A. R., Saravanakumar, B., Jeong, Y. Y., Park, C. H., & Kim, C. S. (2016) · Scientific Reports · doi:10.1038/srep20543 · Cited by 86
Au, K. M., Min, Y., Tian, X., Zhang, L., Perello, V., Caster, J. M., & Wang, A. Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b02913 · Cited by 84
C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
Prylutska, S., Grynyuk, І. І., Matyshevska, O., Prylutskyy, Y. І., Evstigneev, M. P., Scharff, P., & Ritter, U. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0074-4 · Cited by 82
Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)
Guaglianone, P. P., Chan, K. K., Delaflor–Weiss, E., Hanisch, R., Jeffers, S., Sharma, D., & Muggia, F. M. (1994) · Investigational New Drugs · doi:10.1007/bf00874439 · Cited by 81
Magnetic nanoparticle-conjugated polymeric micelles for combined hyperthermia and chemotherapy
Kim, H.-C., Kim, E., Jeong, S. W., Ha, T.-L., Park, S.-I., Lee, S. G., Lee, S. J., & Lee, S. W. (2015) · Nanoscale · doi:10.1039/c5nr04130a · Cited by 80
Self-Assembled Graphene–Dextran Nanohybrid for Killing Drug-Resistant Cancer Cells
Jin, R., Ji, X., Yang, Y., Wang, H., & Cao, A. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am401523y · Cited by 78
Ruttala, H. B., Chitrapriya, N., Kaliraj, K., Ramasamy, T., Shin, W. H., Jeong, J., Kim, J. R., Ku, S., Choi, H., Yong, C. S., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.002 · Cited by 78
Self-citationDavis, J. L., Paris, H. L., Beals, J. W., Binns, S. E., Giordano, G. R., Scalzo, R. L., Schweder, M. M., Blair, E., & Bell, C. (2016) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s39764 · Cited by 77
Platinum nanoparticles induce damage to DNA and inhibit DNA replication
Nejdl, L., Kudr, J., Moulick, A., Hegerova, D., Ruttkay-Nedecký, B., Gumulec, J., Číhalová, K., Šmerková, K., Dostálová, S., Křížková, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180798 · Cited by 77
Shim, G., Kim, J.-Y., Han, J., Chung, S. W., Lee, S., Byun, Y., & Oh, Y. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.026 · Cited by 76
Self-citationZhao, X., Zhao, C., Wang, Y., Li, Y., Du, L., Cui, Z., & Wu, S.-L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57946 · Cited by 76
PEGylated anticancer-carbon nanotubes complex targeting mitochondria of lung cancer cells
Kim, S., Lee, Y. K., Lee, J. Y., Hong, J. H., & Khang, D. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8c31 · Cited by 76
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death
Arlt, M., Haase, D., Hampel, S., Oswald, S., Bachmatiuk, A., Klingeler, R., Schulze, R., Ritschel, M., Leonhardt, A., Fuessel, S., et al. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/33/335101 · Cited by 75
Jung, J., Park, S. J., Chung, H. K., Kang, H.-W., Lee, S.-W., Seo, M. H., Park, H. J., Song, S. Y., Jeong, S., & Choi, E. K. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.02.030 · Cited by 75
Jin, X., Mo, R., Ding, Y., Zheng, W., & Zhang, C. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400340k · Cited by 74
Yuan, Y., Wang, Y., Xing, H.-H., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140605 · Cited by 74
Self-citationSensitization of ovarian cancer cells to cisplatin by gold nanoparticles
Xiong, X., Arvizo, R. R., Saha, S., Robertson, D. J., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2203 · Cited by 73
Yang, C. H., Liu, S., Venkataraman, S., Gao, S. J., Ke, X., Chia, X. T., Hedrick, J. L., & Yang, Y. Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.027 · Cited by 71
Matai, I., Sachdev, A., & Gopinath, P. (2015) · Biomaterials Science · doi:10.1039/c4bm00360h · Cited by 71
Chen, J., Sun, X., Shao, R., Xu, Y., Gao, J., & Liang, W. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s142739 · Cited by 71
Roby, A., Erdoğan, S., & Torchilin, V. P. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4345 · Cited by 69
Zhang, X., Huang, F., Zhang, G., Bai, D.-P., Massimo, D. F., Huang, Y., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144161 · Cited by 68
Self-citationKala, S., Mak, A. S. C., Liu, X., Posocco, P., Pricl, S., Peng, L., & Wong, A. S. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401907z · Cited by 67
Zheng, X. T., Ma, X. Q., & Li, C. M. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.12.052 · Cited by 67
Zhao, L., Yuan, W., Tham, H. P., Chen, H., Xing, P., Xiang, H., Yao, X. S., Qiu, X., Dai, Y., Zhu, L., et al. (2017) · Small · doi:10.1002/smll.201700963 · Cited by 66
Photothermally enhanced photodynamic therapy based on mesoporous Pd@Ag@mSiO2 nanocarriers
Shi, S., Zhu, X., Zhao, Z., Fang, W., Chen, M., Huang, Y., & Chen, X. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00376g · Cited by 65
Chemical Imaging of Platinum-Based Drugs and their Metabolites
Liu, X., & Hummon, A. B. (2016) · Scientific Reports · doi:10.1038/srep38507 · Cited by 64
Zhao, Z., Huang, Y. Z., Shi, S., Tang, S., Li, D. H., & Chen, X. L. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/28/285701 · Cited by 62
Using water-soluble C60 fullerenes in anticancer therapy
Prylutska, S., Бурлака, А. П., Klymenko, P. P., Grynyuk, І. І., Prylutskyy, Y. І., Schütze, C., & Ritter, U. (2011) · Cancer Nanotechnology · doi:10.1007/s12645-011-0020-x · Cited by 62
Li, Y., Tong, Y., Cao, R., Tian, Z., Yang, B., & Yang, P. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54864 · Cited by 61
Gardikis, Κ., Hatziantoniou, S., Bucoş, M., Fessas, D., Signorelli, M., Felekis, T., Zervoú, M., Screttas, C. G., Steele, B. R., Йонов, М., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22121 · Cited by 58
Zogovic, N. S., Nikolić, N., Vranješ‐Đurić, S., Harhaji-Trajkovic, L. M., Vucicevic, L. M., Janjetović, K., Misirkic-Marjanovic, M., Marković, B. M. T., Marković, Z. M., Milonjić, S. K., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.007 · Cited by 57
YOUNG, L. H. Y. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130180013 · Cited by 57
Adil, S. F., Khan, M., Khan, M., Almarri, A. H., Al‐Warthan, A., Alkhathlan, H. Z., Siddiqui, M. R. H., Nayak, V., & Kamal, Ä. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s100903 · Cited by 57
Hekmat, A., Saboury, A. A., & Divsalar, A. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1451 · Cited by 57
Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy
Gad, A. (2016) · International Journal of Nanomedicine and Nanosurgery · doi:10.16966/2470-3206.116 · Cited by 57
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
Son, K. D., & Kim, Y. (2017) · Biomaterials Research · doi:10.1186/s40824-017-0099-1 · Cited by 57
DENDRIMER APPLICATIONS – A REVIEW
Patel, H. (2013) · International Journal of Pharma and Bio Sciences · Cited by 55
Kulhari, H., Pooja, D., Shrivastava, S., Telukutala, S. R., Barui, A. K., Patra, C. R., Vegi, G. M. N., Adams, D. J., & Sistla, R. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.04.007 · Cited by 53
Hiss, D. C., Gabriels, G. A., & Folb, P. I. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-5 · Cited by 51
Gurunathan, S., & Kim, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122549 · Cited by 51
Self-citationMohammad, F., & Yusof, N. A. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.07.025 · Cited by 50
Jang, Y. L., Yun, U. J., Lee, M. S., Kim, M. G., Son, S., Lee, K., Chae, S. Y., Lim, D. W., Kim, H. T., Kim, S. H., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.083 · Cited by 46
Wang, N., Wang, Z., Nie, S., Song, L., He, T., Yang, S., Yang, X., Cheng, Y., Wu, Q., & Gong, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124843 · Cited by 46
Nanoparticles for Effective Combination Therapy of Cancer
Jadia, R., Scandore, C., & Rai, P. (2016) · International Journal of Nanotechnology and Nanomedicine · doi:10.33140/ijnn/01/01/00003 · Cited by 44
Kuruvilla, S. P., Tiruchinapally, G., Crouch, A. C., ElSayed, M. E. H., & Greve, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181944 · Cited by 43
Lin, Y.-W., Raj, E. N., Liao, W., Lin, J., Liu, K., Chen, T.-H., Cheng, H.-C., Wang, C.-C., Li, L. Y., Chen, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09983-8 · Cited by 43
Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs
Surnar, B., & Jayakannan, M. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01608 · Cited by 42
Kumar, P., Wasim, L., Chopra, M., & Chhikara, A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0863-5 · Cited by 42
Rochani, A., Sivakumar, B., Girija, A. R., Raveendran, S., Borah, A., Nagaoka, Y., Nakajima, Y., Maekawa, T., & Kumar, D. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.048 · Cited by 38
Engineering of a Pluronic F127 functionalized magnetite/graphene nanohybrid for chemophototherapy
Li, Y., Liu, J., Dong, H., Liu, G., & Hu, H. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/6/065602 · Cited by 37
Zhang, T., Xiong, H., Dahmani, F. Z., Sun, L., Li, Y., Li, Y., Zhou, J., & Yao, J. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/14/145101 · Cited by 37
Liao, F., Saitoh, Y., & Miwa, N. (2011) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504011x12970940207805 · Cited by 37
Banu, H., Stanley, B., Faheem, S. M., Renuka, N., Premkumar, K., & Vasanthakumar, G. (2014) · Plasmonics · doi:10.1007/s11468-014-9747-7 · Cited by 36
Wang, T., Yang, S., Mei, L. A., Parmar, C. K., Gillespie, J. W., Praveen, K. P., Petrenko, V. A., & Torchilin, V. P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0052 · Cited by 35
Tan, J. M., Karthivashan, G., Gani, S. A., Fakurazi, S., & Hussein, M. Z. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5635-8 · Cited by 34
Zhang, X., Yan, Q., Shen, W., & Gurunathan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081354 · Cited by 34
Self-citation
Flagged first, then by citations
1 of the 220 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mewani, 2004, Analysis of gene expression in breast cancer cells treated with antisense raf oligonucleotide using microarray, Proc. Am. Assoc. Cancer Res., 64, 1209
Cited by
Sorted by citations
Magnetic Nanoparticles in Cancer Therapy and Diagnosis
Farzin, A., Etesami, S. A., Quint, J. P., Memić, A., & Tamayol, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901058 · Cited by 597
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 573
Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Nanomaterials · doi:10.3390/nano10091700 · Cited by 411
Gaur, M., Misra, C., Yadav, A. B., Swaroop, S., Maolmhuaidh, F. Ó., Bechelany, M., & Barhoum, A. (2021) · Materials · doi:10.3390/ma14205978 · Cited by 332
Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature
Barani, M., Sangiovanni, E., Angarano, M., Rajizadeh, M. A., Mehrabani, M., Piazza, S., Gangadharappa, H. V., Pardakhty, A., Mehrbani, M., Dell’Agli, M., et al. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s318416 · Cited by 308
Metadata
- Authors
- Gurunathan, S., Kang, M.-H., Qasim, M., & Kim, J.-H.
- Affiliations
- Konkuk University (KR)
- Corresponding author
- Gurunathan, Sangiliyandi
- Kim, Jin-Hoi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-20
- Volume
- 19
- Issue
- 10
- Pages
- 3264
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6214025
- OpenAlex
- W2896053285
- Cited by
- 367
- References
- 220
- Citations by year
- 2026: 26 · 2025: 55 · 2024: 55 · 2023: 51 · 2022: 57 · 2021: 52 · 2020: 47 · 2019: 24
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- cancer nanomedicine, multidrug resistance, anticancer drug delivery, liposomes, polymeric micelles, dendrimers, carbon nanotubes, graphene oxide, nanodiamonds, C60, metal nanoparticles, angiogenesis, theranostic nanocarriers, drug synergy
- MeSH terms
- Animals, Antineoplastic Agents, Drug Therapy, Combination, Humans, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review